ETF Copilot

FHLC vs IBB: holdings overlap, shared companies and scores

As of October 28, 2026, FHLC and IBB overlap 18.6% by weight. Fidelity MSCI Health Care Index ETF (FHLC): U.S. healthcare companies iShares Biotechnology ETF (IBB): U.S. biotechnology stocks.

Updated October 28, 2026

Where FHLC and IBB trade against their own history

FHLC trades at 32.8 times earnings, against its own median of 25.3, and is more expensive than 98% of its own last 9 years.

IBB trades at 28.9 times earnings, against its own median of 21.6, and is more expensive than 88% of its own last 7 years.

What moved FHLC and IBB this week

FHLC rose 0.8% in the week to October 28, 2026. The holdings that moved it most were Johnson & Johnson (+5.1%), Eli Lilly (+1.4%) and Amgen (+3.1%); Merck (−6.0%) pushed the other way.

IBB rose 2.3% in the week to October 28, 2026. The holdings that moved it most were Genmab A/S (+44.8%), Gilead Sciences (+3.7%) and Amgen (+3.1%); Moderna (−12.9%) pushed the other way.

What do FHLC and IBB each hold?

What's inside FHLC: AI 0%.

52% of FHLC is its ten largest holdings.

What's inside IBB: AI 1%.

51% of IBB is its ten largest holdings.

How much do FHLC and IBB overlap? 18.6% by weight

As of October 28, 2026, FHLC and IBB overlap 18.6% by weight.

19% of FHLC is already inside IBB.

88% of IBB is already inside FHLC.

FHLC holds 326 companies and IBB holds 240; 138 are in both.

Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.

How does ETF Copilot score FHLC and IBB? 5.3 and 4.3 out of 10

As of October 28, 2026, ETF Copilot scores FHLC 5.3 out of 10 and IBB 4.3 out of 10.

They differ most on Risk: FHLC 8.2 and IBB 2.8.

The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.

FHLC vs IBB — ETF Copilot factor scores, 0–10
FactorFHLCIBB
Growth6.29.5
Value0.90.2
Risk8.22.8
Quality5.60.9
Return5.15.0

FHLC is the cheaper of the two at 0.08% a year

As of October 28, 2026, FHLC charges 0.08% a year, yields 1.17% and holds $3.8B in assets across 326 positions.

As of October 28, 2026, IBB charges 0.44% a year, yields 0.14% and holds $11.0B in assets across 240 positions.

FHLC vs IBB — cost, income and size
MeasureFHLCIBB
Expense ratio0.08%0.44%
Dividend yield1.17%0.14%
Assets under management$3.8B$11.0B
Holdings326240

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Compare with similar funds

Cite this

ETF Copilot, “FHLC vs IBB holdings overlap and scores”, as of October 28, 2026.
https://etf-copilot.com/compare/fhlc-vs-ibb

  1. Fidelity MSCI Health Care Index ETF (FHLC)
  2. iShares Biotechnology ETF (IBB)

ETF Copilot Pro unlocks FHLC vs IBB prices and holdings.

Try Pro free →